English
简体中文
Total: £ 56.28
Published Date: 2024-12-04 | Pages: 95 | Tables: 153 | Medical Care
The global market for Live Biotherapeutic Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Live Biotherapeutic Products, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Live Biotherapeutic Products by region & country, by Type, and by Application.
The Live Biotherapeutic Products market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Biotherapeutic Products.
Market Segmentation
By Company
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Segment by Type:
Solids
Oral Liquids
Injectables
Others
Segment by Application
Autoimmune Disease
Digestive System Diseases
Infectious Disease
Metabolic Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Live Biotherapeutic Products manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Live Biotherapeutic Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Live Biotherapeutic Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Live Biotherapeutic Products Product Introduction
1.2 Global Live Biotherapeutic Products Market Size Forecast
1.3 Live Biotherapeutic Products Market Trends & Drivers
1.3.1 Live Biotherapeutic Products Industry Trends
1.3.2 Live Biotherapeutic Products Market Drivers & Opportunity
1.3.3 Live Biotherapeutic Products Market Challenges
1.3.4 Live Biotherapeutic Products Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Live Biotherapeutic Products Players Revenue Ranking (2023)
2.2 Global Live Biotherapeutic Products Revenue by Company (2019-2024)
2.3 Key Companies Live Biotherapeutic Products Manufacturing Base Distribution and Headquarters
2.4 Key Companies Live Biotherapeutic Products Product Offered
2.5 Key Companies Time to Begin Mass Production of Live Biotherapeutic Products
2.6 Live Biotherapeutic Products Market Competitive Analysis
2.6.1 Live Biotherapeutic Products Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Live Biotherapeutic Products Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Solids
3.1.2 Oral Liquids
3.1.3 Injectables
3.1.4 Others
3.2 Global Live Biotherapeutic Products Sales Value by Type
3.2.1 Global Live Biotherapeutic Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Live Biotherapeutic Products Sales Value, by Type (2019-2030)
3.2.3 Global Live Biotherapeutic Products Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Autoimmune Disease
4.1.2 Digestive System Diseases
4.1.3 Infectious Disease
4.1.4 Metabolic Disease
4.1.5 Others
4.2 Global Live Biotherapeutic Products Sales Value by Application
4.2.1 Global Live Biotherapeutic Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Live Biotherapeutic Products Sales Value, by Application (2019-2030)
4.2.3 Global Live Biotherapeutic Products Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Live Biotherapeutic Products Sales Value by Region
5.1.1 Global Live Biotherapeutic Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Live Biotherapeutic Products Sales Value by Region (2019-2024)
5.1.3 Global Live Biotherapeutic Products Sales Value by Region (2025-2030)
5.1.4 Global Live Biotherapeutic Products Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Live Biotherapeutic Products Sales Value, 2019-2030
5.2.2 North America Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Live Biotherapeutic Products Sales Value, 2019-2030
5.3.2 Europe Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Live Biotherapeutic Products Sales Value, 2019-2030
5.4.2 Asia Pacific Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Live Biotherapeutic Products Sales Value, 2019-2030
5.5.2 South America Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Live Biotherapeutic Products Sales Value, 2019-2030
5.6.2 Middle East & Africa Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Live Biotherapeutic Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Live Biotherapeutic Products Sales Value
6.3 United States
6.3.1 United States Live Biotherapeutic Products Sales Value, 2019-2030
6.3.2 United States Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Live Biotherapeutic Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Live Biotherapeutic Products Sales Value, 2019-2030
6.4.2 Europe Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Live Biotherapeutic Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Live Biotherapeutic Products Sales Value, 2019-2030
6.5.2 China Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Live Biotherapeutic Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Live Biotherapeutic Products Sales Value, 2019-2030
6.6.2 Japan Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Live Biotherapeutic Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Live Biotherapeutic Products Sales Value, 2019-2030
6.7.2 South Korea Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Live Biotherapeutic Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Live Biotherapeutic Products Sales Value, 2019-2030
6.8.2 Southeast Asia Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Live Biotherapeutic Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Live Biotherapeutic Products Sales Value, 2019-2030
6.9.2 India Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Live Biotherapeutic Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Capsugel
7.1.1 Capsugel Profile
7.1.2 Capsugel Main Business
7.1.3 Capsugel Live Biotherapeutic Products Products, Services and Solutions
7.1.4 Capsugel Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.1.5 Capsugel Recent Developments
7.2 Jeneil Biotech
7.2.1 Jeneil Biotech Profile
7.2.2 Jeneil Biotech Main Business
7.2.3 Jeneil Biotech Live Biotherapeutic Products Products, Services and Solutions
7.2.4 Jeneil Biotech Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.2.5 Jeneil Biotech Recent Developments
7.3 UAS Labs
7.3.1 UAS Labs Profile
7.3.2 UAS Labs Main Business
7.3.3 UAS Labs Live Biotherapeutic Products Products, Services and Solutions
7.3.4 UAS Labs Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.3.5 Biose Recent Developments
7.4 Biose
7.4.1 Biose Profile
7.4.2 Biose Main Business
7.4.3 Biose Live Biotherapeutic Products Products, Services and Solutions
7.4.4 Biose Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.4.5 Biose Recent Developments
7.5 Cerbios-Pharma
7.5.1 Cerbios-Pharma Profile
7.5.2 Cerbios-Pharma Main Business
7.5.3 Cerbios-Pharma Live Biotherapeutic Products Products, Services and Solutions
7.5.4 Cerbios-Pharma Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.5.5 Cerbios-Pharma Recent Developments
7.6 Inpac Probiotics
7.6.1 Inpac Probiotics Profile
7.6.2 Inpac Probiotics Main Business
7.6.3 Inpac Probiotics Live Biotherapeutic Products Products, Services and Solutions
7.6.4 Inpac Probiotics Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.6.5 Inpac Probiotics Recent Developments
7.7 NIZO
7.7.1 NIZO Profile
7.7.2 NIZO Main Business
7.7.3 NIZO Live Biotherapeutic Products Products, Services and Solutions
7.7.4 NIZO Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.7.5 NIZO Recent Developments
7.8 Winclove Probiotics
7.8.1 Winclove Probiotics Profile
7.8.2 Winclove Probiotics Main Business
7.8.3 Winclove Probiotics Live Biotherapeutic Products Products, Services and Solutions
7.8.4 Winclove Probiotics Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.8.5 Winclove Probiotics Recent Developments
7.9 BJP Laboratories
7.9.1 BJP Laboratories Profile
7.9.2 BJP Laboratories Main Business
7.9.3 BJP Laboratories Live Biotherapeutic Products Products, Services and Solutions
7.9.4 BJP Laboratories Live Biotherapeutic Products Revenue (US$ Million) & (2019-2024)
7.9.5 BJP Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Live Biotherapeutic Products Industrial Chain
8.2 Live Biotherapeutic Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Live Biotherapeutic Products Sales Model
8.5.2 Sales Channel
8.5.3 Live Biotherapeutic Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Live Biotherapeutic Products Market Trends
Table 2. Live Biotherapeutic Products Market Drivers & Opportunity
Table 3. Live Biotherapeutic Products Market Challenges
Table 4. Live Biotherapeutic Products Market Restraints
Table 5. Global Live Biotherapeutic Products Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Live Biotherapeutic Products Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Live Biotherapeutic Products Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Live Biotherapeutic Products Product Type
Table 9. Key Companies Time to Begin Mass Production of Live Biotherapeutic Products
Table 10. Global Live Biotherapeutic Products Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Live Biotherapeutic Products Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Live Biotherapeutic Products Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Live Biotherapeutic Products Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Live Biotherapeutic Products Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Live Biotherapeutic Products Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Live Biotherapeutic Products Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Live Biotherapeutic Products Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Live Biotherapeutic Products Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Live Biotherapeutic Products Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Live Biotherapeutic Products Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Live Biotherapeutic Products Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Live Biotherapeutic Products Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Live Biotherapeutic Products Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Live Biotherapeutic Products Sales Value by Region (2019-2024) & (%)
Table 27. Global Live Biotherapeutic Products Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Live Biotherapeutic Products Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Live Biotherapeutic Products Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Live Biotherapeutic Products Sales Value, (2025-2030) & (US$ Million)
Table 31. Capsugel Basic Information List
Table 32. Capsugel Description and Business Overview
Table 33. Capsugel Live Biotherapeutic Products Products, Services and Solutions
Table 34. Revenue (US$ Million) in Live Biotherapeutic Products Business of Capsugel (2019-2024)
Table 35. Capsugel Recent Developments
Table 36. Jeneil Biotech Basic Information List
Table 37. Jeneil Biotech Description and Business Overview
Table 38. Jeneil Biotech Live Biotherapeutic Products Products, Services and Solutions
Table 39. Revenue (US$ Million) in Live Biotherapeutic Products Business of Jeneil Biotech (2019-2024)
Table 40. Jeneil Biotech Recent Developments
Table 41. UAS Labs Basic Information List
Table 42. UAS Labs Description and Business Overview
Table 43. UAS Labs Live Biotherapeutic Products Products, Services and Solutions
Table 44. Revenue (US$ Million) in Live Biotherapeutic Products Business of UAS Labs (2019-2024)
Table 45. UAS Labs Recent Developments
Table 46. Biose Basic Information List
Table 47. Biose Description and Business Overview
Table 48. Biose Live Biotherapeutic Products Products, Services and Solutions
Table 49. Revenue (US$ Million) in Live Biotherapeutic Products Business of Biose (2019-2024)
Table 50. Biose Recent Developments
Table 51. Cerbios-Pharma Basic Information List
Table 52. Cerbios-Pharma Description and Business Overview
Table 53. Cerbios-Pharma Live Biotherapeutic Products Products, Services and Solutions
Table 54. Revenue (US$ Million) in Live Biotherapeutic Products Business of Cerbios-Pharma (2019-2024)
Table 55. Cerbios-Pharma Recent Developments
Table 56. Inpac Probiotics Basic Information List
Table 57. Inpac Probiotics Description and Business Overview
Table 58. Inpac Probiotics Live Biotherapeutic Products Products, Services and Solutions
Table 59. Revenue (US$ Million) in Live Biotherapeutic Products Business of Inpac Probiotics (2019-2024)
Table 60. Inpac Probiotics Recent Developments
Table 61. NIZO Basic Information List
Table 62. NIZO Description and Business Overview
Table 63. NIZO Live Biotherapeutic Products Products, Services and Solutions
Table 64. Revenue (US$ Million) in Live Biotherapeutic Products Business of NIZO (2019-2024)
Table 65. NIZO Recent Developments
Table 66. Winclove Probiotics Basic Information List
Table 67. Winclove Probiotics Description and Business Overview
Table 68. Winclove Probiotics Live Biotherapeutic Products Products, Services and Solutions
Table 69. Revenue (US$ Million) in Live Biotherapeutic Products Business of Winclove Probiotics (2019-2024)
Table 70. Winclove Probiotics Recent Developments
Table 71. BJP Laboratories Basic Information List
Table 72. BJP Laboratories Description and Business Overview
Table 73. BJP Laboratories Live Biotherapeutic Products Products, Services and Solutions
Table 74. Revenue (US$ Million) in Live Biotherapeutic Products Business of BJP Laboratories (2019-2024)
Table 75. BJP Laboratories Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Live Biotherapeutic Products Downstream Customers
Table 79. Live Biotherapeutic Products Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Live Biotherapeutic Products Product Picture
Figure 2. Global Live Biotherapeutic Products Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Live Biotherapeutic Products Sales Value (2019-2030) & (US$ Million)
Figure 4. Live Biotherapeutic Products Report Years Considered
Figure 5. Global Live Biotherapeutic Products Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Live Biotherapeutic Products Revenue in 2023
Figure 7. Live Biotherapeutic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Solids Picture
Figure 9. Oral Liquids Picture
Figure 10. Injectables Picture
Figure 11. Others Picture
Figure 12. Global Live Biotherapeutic Products Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Live Biotherapeutic Products Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Autoimmune Disease
Figure 15. Product Picture of Digestive System Diseases
Figure 16. Product Picture of Infectious Disease
Figure 17. Product Picture of Metabolic Disease
Figure 18. Product Picture of Others
Figure 19. Global Live Biotherapeutic Products Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Live Biotherapeutic Products Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Live Biotherapeutic Products Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Live Biotherapeutic Products Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Live Biotherapeutic Products Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Live Biotherapeutic Products Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Live Biotherapeutic Products Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Live Biotherapeutic Products Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Live Biotherapeutic Products Sales Value (%), (2019-2030)
Figure 32. United States Live Biotherapeutic Products Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Live Biotherapeutic Products Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Live Biotherapeutic Products Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Live Biotherapeutic Products Sales Value by Application (%), 2023 VS 2030
Figure 38. China Live Biotherapeutic Products Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
Figure 40. China Live Biotherapeutic Products Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Live Biotherapeutic Products Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Live Biotherapeutic Products Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Live Biotherapeutic Products Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Live Biotherapeutic Products Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Live Biotherapeutic Products Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Live Biotherapeutic Products Sales Value by Application (%), 2023 VS 2030
Figure 50. India Live Biotherapeutic Products Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Live Biotherapeutic Products Sales Value by Type (%), 2023 VS 2030
Figure 52. India Live Biotherapeutic Products Sales Value by Application (%), 2023 VS 2030
Figure 53. Live Biotherapeutic Products Industrial Chain
Figure 54. Live Biotherapeutic Products Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
